Stephen L. Huhn - Aug 13, 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
CMO & Sr VP, Clinical Dev.
Signature
/s/ Peter Slover, Attorney-in-Fact
Stock symbol
CTNM
Transactions as of
Aug 13, 2024
Transactions value $
$12,928
Form type
4
Date filed
8/14/2024, 06:03 PM
Previous filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTNM Class A Common Stock Options Exercise $12.9K +12.8K $1.01* 12.8K Aug 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTNM Stock Option (right to buy) Options Exercise $0 -12.8K -7.35% $0.00 161K Aug 13, 2024 Class A Common Stock 12.8K $1.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of Class A Common Stock.
F2 Options granted under the Issuer's 2012 Equity Incentive Plan. The option is fully vested.